Our fantasy football analysts sat down with an orthopedic sports surgeon, Dr. Deepak Chona, to break down the injuries most likely to shape draft-day decisions this year, working through severity, realistic recovery timelines, and reinjury risk for each name. Here’s the full breakdown of fantasy football injury updates to know, organized by where these players are going in drafts.
- 2026 Fantasy Football Expert Rankings
- Fantasy Football Dynasty Rankings
- Fantasy Football Trade Analyzer
- Best Fantasy Football Rankings
2026 Fantasy Football Draft Advice: Injury Updates to Know
Early-Round Injuries
Dealing with what’s being described as a hip flexor and sports hernia issue, Nacua has already shown positive signs, including running against resistance on the sideline. Minor muscle strains like this one carry a real but modest reinjury risk, and our medical expert doesn’t see a reason to meaningfully downgrade him based on the injury itself. The bigger question mark is a possible suspension unrelated to his health, though our analysts view that as more likely a warning than a certainty at this point.
In and out of practice with general muscle tightness, McCaffrey’s team has described this as a deliberate ramp-up-and-down plan ahead of week one. Our medical expert fully endorses that approach specifically for a player with his soft-tissue history and age, noting that real load management applies to total practice workload, not just game-day touches, and that despite an extensive injury history, he’s actually missed just one game in three of the last four years. Both analysts remain comfortable drafting him in the back half of the first round, though they agree he’s become a conditional RB1 who requires pairing with another real lead back as insurance.
Jeanty suffered what’s being described as a sprained ankle in practice, and initial media reaction likely overstated its severity. Our medical expert flags real concern that outside reporting calling it “not nothing” could mean this is a high ankle sprain rather than a low one, a distinction that matters enormously: a low ankle sprain points toward a normal week one return with minimal dip, while a genuine high ankle sprain carries a real multi-week absence plus an additional efficiency ramp-up period even after returning, making week one unlikely and week two or three a more realistic best case. Both analysts have moved him down meaningfully in response, and both agree drafting his primary backup is now a real requirement if rostering Jeanty at his adjusted price.
Nabers shed his no-contact practice jersey for the first time, with real positive public comments from his head coach suggesting a reasonable expectation of a week one return barring a new setback. Our medical expert has grown notably more optimistic, though still flags a typical four-week ramp-up period in snap count and target volume even upon return, plus a real efficiency dip early on before climbing back toward normal by around week six. One analyst has come fully around given the positive news and still ranks him as a genuine early second-round pick, while the other remains invested but more cautious, citing broader team-level concerns beyond Nabers’s own recovery.
Mid-Round Injuries
Love suffered a high ankle sprain roughly a week and a half before this recording, with his team publicly hopeful for a week one return. Our medical expert notes that initial reporting suggesting real week one doubt implied a moderate-severity injury and a typical six-week production dip window, though more recent team comments describing him as through the first phase of recovery suggest a milder outcome than initially feared. Real elevated reinjury risk remains a factor if the injury is on the more severe end. One analyst has moved him down meaningfully and is fully out at his current cost, preferring a specific complementary backfield option instead, while the other remains comfortable drafting him as a high-risk, high-reward asset, recommending that same handcuff be added a few rounds later regardless.
A reported toe sprain, described by outside reporting as stable, reads to our medical expert as real evidence of a milder-than-worst-case injury, likely turf toe, with a reasonable expectation of a normal or only mildly reduced week one outing. Real skepticism about this specific team’s own public injury messaging track record tempers how much weight to put on vague coaching comments either way. Both analysts remain comfortable holding or buying Egbuka at his current cost, expecting a normal week one return regardless of the ambiguous public commentary.
A groin strain suffered roughly two weeks before this recording ended Burden’s preseason early, but real positive signs have already emerged, including light jogging work about a week and a half after the injury was announced, plus supportive public comments from a teammate suggesting he’s on track for week one. The general reinjury risk for this type of strain is real but modest. A broader question about whether certain players are simply prone to recurring soft-tissue injuries gets a nuanced answer: a specific past case found an underlying strength imbalance between sides that a specialist later identified and corrected, suggesting this kind of pattern can often be a real, correctable issue rather than a permanent risk factor, especially for younger players.
A groin injury suffered about a week before this recording has been publicly downplayed by his team, and real-time ADP hasn’t meaningfully moved in response. Our medical expert notes the team’s own one-week absence expectation implies a low long-term risk profile, not enough to warrant a real ranking downgrade on its own. Both analysts remain fully unmoved on Warren, including by a separate roster addition that one believes affects a different teammate’s outlook far more than his own.
Pierce hasn’t practiced since signing a notable contract extension, due to a lingering left ankle issue reportedly dating back through last season, with the team reportedly choosing an initial non-surgical treatment path despite knowing it carried real risk of lingering into this year. Our medical expert notes that even with a near-term return, a real multi-week practice-participation ramp-up would still be required, generating real hesitation about banking on him early in the season, though a surgical path later in the year would carry a more favorable recovery outlook by around midseason. Both analysts have moved off him at his current cost, citing added target competition from a new veteran signing at his own position as a further reason for caution.
Jonathon Brooks (RB – CAR) and Chuba Hubbard (RB – CAR)
Hubbard suffered a hamstring injury earlier in the preseason, described by outside reporting using notably strong language that our medical expert reads as signaling above-average severity, with the team’s own public expectation for a week one return described as non-guaranteed. On Brooks specifically, real favorable medical framing centers on his specific recovery timeline, now well past the point where lingering deficits are typically still expected following his second ACL tear, combined with real elite underlying talent. One analyst has fully flipped his personal rankings to prefer Brooks over Hubbard, citing real positive camp performance and a belief that Hubbard’s own disappointing season last year traced to an injury that dogged him for months, now compounded by this fresh hamstring issue. Both analysts frame the backfield as likely to remain a real committee situation regardless of which back leads early.
Rookie Watch
A recurring hamstring issue is now expected to cost Tyson roughly two months, driving a significant real-time ADP decline. Our medical expert projects that absence to split roughly evenly between missing the start of the season and missing time into it, with a return likely followed by a typical four-week additional ramp-up in volume. Rookies who miss significant training camp time historically don’t tend to start strong even once activated, tempering short-term expectations further despite clearly real underlying talent. A longer-term prognosis concern also applies given a real multi-ligament knee injury history from college, an important consideration specifically for dynasty-format investors. Both analysts are fully out on Tyson for this redraft season given his extensive recent injury track record, while agreeing he represents a real buy-low target specifically in dynasty formats once his value is depressed.
View the Best Fantasy Football Team Names 
Fantasy Football Draft Rankings
Check out the consensus 2026 fantasy football draft rankings from our experts.
Subscribe: Apple Podcasts | Spotify | SoundCloud | iHeartRadio
